Condition: Lumbosacral Radiculopathy · Sponsor: Sollis Therapeutics, Inc.
This study will evaluate the safety and effectiveness of a new pain medication in development, clonidine micropellet. Participants will receive a single injection of either clonidine micropellet or sham injection for the treatment of low back and leg pain from sciatica.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Sollis Clinical Study Site 36 | Mobile, Alabama, United States | — |
| Sollis Clinical Study Site #41 | Phoenix, Arizona, United States | — |
| Sollis Clinical Study Site #44 | Phoenix, Arizona, United States | — |
| Sollis Clinical Study Site 29 | Scottsdale, Arizona, United States | — |
| Sollis Clinical Study Site 40 | Tucson, Arizona, United States | — |
| Sollis Clinical Study Site 49 | Rancho Mirage, California, United States | — |
| Sollis Clinical Study Site 28 | Santa Rosa, California, United States | — |
| Sollis Clinical Study Site 30 | Washington D.C., District of Columbia, United States | — |
| Sollis Clinical Study Site 35 | Fort Lauderdale, Florida, United States | — |
| Sollis Clinical Study Site 38 | Miami, Florida, United States | — |
| Sollis Clinical Study Site 12 | Bloomington, Illinois, United States | — |
| Sollis Clinical Study Site 13 | Chicago, Illinois, United States | — |
+ 21 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03727100